SPY423.48-0.83 -0.20%
DIA342.96-2.16 -0.63%
IXIC14,114.20+44.78 0.32%

BRIEF-Cytosorbents Awarded $1.5 Million Sequential Phase II Sbir Contract To Advance The Treatment Of Severe Hyperkalemia In Traumatic Injury

05/11/2021 08:54
BRIEF-Cytosorbents Awarded $1.5 Million Sequential Phase II Sbir Contract To Advance The Treatment Of Severe Hyperkalemia In Traumatic Injury

- Cytosorbents Corp CTSO.O:

  • CYTOSORBENTS AWARDED $1.5 MILLION SEQUENTIAL PHASE II SBIR CONTRACT TO ADVANCE THE TREATMENT OF SEVERE HYPERKALEMIA IN TRAUMATIC INJURY

Source text for Eikon: ID:nPn4hyqGWa

Further company coverage: CTSO.O


(([email protected];))